Seelos Therapeutics Stock Price. Everything You Need To Know About The Seelos Therapeutics Stock!
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 15 full-time employees. The firm is engaged in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The firm operates under one segment which develops pharmaceutical products. The firm’s programs include SLS-002 for the potential treatment of acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia (SCA). SLS-002 is intranasal racemic ketamine with two investigational new drug applications (INDs). SLS-005 is used for the potential treatment of Sanfilippo Syndrome. SLS-005 is IV trehalose, a protein stabilizer that crosses the blood-brain barrier and activates autophagy and the lysosomal pathway. The firm’s ongoing programs include SLS-004, SLS-006, and SLS-007.
Seelos Therapeutics Stock Price. Everything You Need To Know About The Seelos Therapeutics Stock! performance
- Employees 15
- Company HQ New York City
- Website https://seelostherapeutics.com/
- SEEL Asset Type Common Stock
- SEEL Market Capitalization 4M
- Earnings Per Share -7.73
- Dividends Per Share None
- Dividend Date 2019-01-24
- Quarterly Earnings Growth 0
Seelos Therapeutics, a pioneering biopharmaceutical company, presents a promising investment opportunity for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. With Zorion, you can easily navigate and invest in Seelos Therapeutics stocks and be part of the groundbreaking advancements in neurology and psychiatry. Seelos is committed to developing innovative therapies for patients suffering from neurological disorders, including Parkinson’s disease and suicidal ideation. By investing in Seelos, you are not only supporting their mission to improve the quality of life for millions of people, but you also have the potential to generate substantial returns on your investment. Zorion provides all the resources and educational materials you need to make informed decisions and stay updated with the latest insights and recommendations. Start investing in Seelos Therapeutics today with Zorion and be part of the future of neurology and psychiatry.
